Center for Regenerative Medicine
Center for Regenerative Medicine is a registered organization established with the goal to produce lifesaving next-generation medicines in Nepal. It comprises a team of Nepalese professionals coming from scientific, clinical, diagnostic, and public health backgrounds. Our immediate goal is to bring the promise of the United States Food and Drug Administration (US-FDA) and European Medicines Agency (EMA) approved engineered T-cell therapy and Immune-Oncology drugs to as many eligible Nepalese patients as possible who may benefit.
Our Science
Our technology uses the power of a person's own immune system to target and attack their cancer. As one of the first one of the first next generation medicine organization in the developing world, we promise to focus on producing high-quality therapeutics with indigenously developed manufacturing plants. We believe the Immuno-Oncology modality has the power to transform terminally ill patients with cancer and other incurable diseases , so we’re pursuing all potential avenues to help bring it to those who need it in our country.
Drug Pipeline Programs:
Drug Pipeline Programs I
Autologous cell product (Engineered) for hematological malignancies Acute Lymphoblastic Leukemia (ALL) , Non-Hodgkin Lymphoma (NHL) , and Mantle Cell lymphoma (MCL)
Drug Pipeline Programs II
Autologous cell product (Engineered) for Multiple myeloma
Drug Pipeline Programs III
Autologous cell product (Naturally Occurring) for metastatic melanoma
Drug Pipeline Programs IV
Autologous cell product (Engineered) for Hepatocellular Carcinoma (HCC )and Liver diseases
Meet Our Teams
Collaborations:
We believe in working together as demonstrated by our extensive International and National collaborations to advance science and manufacturing of NextGen drugs.
Enabling Sucess
We can help you achieve your goals. Start the process with a brief scientific consultation to determine how we can help.
